RxDoctor Payments Data

Juan Santiago Torres, MD

Orthopaedic Surgery · Hatillo, PRNPI 1700234101

Payments from drug & device makers

What this record shows

This record is dominated by grants: $15,000 of the $23,700 with a category attached, or 63.3%. 8 manufacturers reported payments, led by Smith+Nephew at 44.0% of the total. Reporting peaked in 2023 at $16,111 and has fallen 68.8% since, to $5,022 in 2024. Among orthopaedic surgery clinicians in PR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$23,700in general payments, 2019–2025

Across 18 payments — averaging $1316.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$10K
  • Arthrex$10K
  • CDC Medical LLC$2K
  • Stryker$330
  • Si-bone, Inc.$220
  • Depuy Synthes Products, Inc.$167
  • plus $163 from 2 others

What the payments were for

  • Grants$15,00063%
  • Food & beverage$1,3005%
  • Education$7,40031%

General payments by program year

22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$23,700 in reported general payments places this provider in the 95th percentile of 94 orthopaedic surgery providers in Puerto Rico.

See all orthopaedic surgery providers in Puerto Rico

Medicare billing

Part B allowed, 2024
$65,510
Medicare patients
119
Services billed
464

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam120$367
Celecoxib12$283
Methylprednisolone42$202
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen23$152
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen26$123
Ciprofloxacin Hcl12$110
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim17$78
Cephalexin12$71
Ibuprofen15$27

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Hatillo

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →